Brief Recap and Updates on the MarketsAnalyst Actions and Comments - AUPHStock News Watch Items - CARA, ABEO Dow +72.85 at 24946.51, Nasdaq +0.25 at 7481.98, S&P +4.68 at 2752.01 Stocks were a little higher on Friday in a relatively quiet trading day considering it was a quad options expiration day. The energy sector was the top performer up about 1% on the day. The price of WTI crude gained roughly 2.0% at $62.35 per barrel. Technology stocks were weak on Friday and further weakness is indicated for Monday's market open. As of 6 am EST Monday, Nasdaq futures were down about 87 points. The S&P 500 is still testing its 50-day moving average. The futures are pointing towards a lower opening Monday morning. The S&P 500 futures were pointing towards a 15 point loss. This would place the SPY under the 50-day MA and is something to keep an eye on.Note: The VIX is up 7% this morning in pre-markets.VIX16.91 +1.11+7.03% Nasdaq Composite: +8.4% YTDS&P 500: +2.9% YTDDow Jones Industrial Average: +0.9% YTDRussell 2000: +3.3% YTD [Repeated from Friday's briefing] Aurinia Pharmaceuticals' $AUPH price target was raised to $16 from $14 at Cantor Fitzgerald on Friday. The analyst reiterated his Overweight rating on the company. The company's estimated tax rate will be declining to 21% from 35%Remains on schedule to enroll its Phase 3 Aurora studyStudies to be initiated to advance its pipeline indications for voclosporin in Q2 Cara Therapeutics $CARA continues to show weakness after an earnings miss last week and a price target cut by Canaccord Genuity. I have noticed this stock has had support at the $12.50 level in the past. Maybe something to watch here. $CARA, Cara Therapeutics, Inc. / H1 Abeona Therapeutics $ABEO reported Q4 EPS of ($0.19) vs estimates of ($0.14). Cash, cash equivalents and marketable securities as of December 31, 2017 were $137.8 million, compared to $56.5 million as of September 30, 2017. Abeona will hold a conference call to update clinical developments on March 27th. This stock may present some trading opportunities as it has been very volatile. $ABEO, Abeona Therapeutics Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. Follow us and check back occasionally for additional articles or posts.